Clinical Trials Sponsored by C. Dillard

Total 607 results

C. R. Bard

Terminated

Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement

Primary Focus: Adult Subjects Who Require PICC Placement

United States
C. R. Bard

Terminated

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

Vascular Access Complication

United States
C. R. Bard

Completed

Progel Vascular Sealant

Aortic Valve Stenosis | Aortic Valve Disorder | Aneurysm of Ascending Aorta | Bicuspid Valve Disorder

United States
C. R. Bard

Completed

Post-Approval Study for the FLAIR Endovascular Stent Graft (RENOVA)

Stenosis of Vascular Prosthetic Devices, Implants and Grafts

United States
C. R. Bard

Completed

AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use

Vascular Access Complication

United States
C. R. Bard

Completed

Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System (MODUS)

Indication for Peripheral Intravenous Catheterization

United States
C. R. Bard

Completed

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP) (NASCENT)

Respiratory Failure

United States
C. R. Bard

Completed

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

Coronary Artery Stenosis

Netherlands
C. R. Bard

Completed

Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation (True™Flow)

Aortic Valve Stenosis

Germany
C. R. Bard

Completed

FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis (RESCUE)

Restenosis

United States
C. R. Bard

Terminated

Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters (DISTAL)

Cancer

United States
C. R. Bard

Completed

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Pulmonary Embolism

United States
C. R. Bard

Completed

GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation (GENESIS)

Paroxysmal Atrial Fibrillation

Canada, Germany, United Kingdom
C. R. Bard

Completed

RF Ablation of Atrial Fibrillation

Atrial Fibrillation

United States
C. R. Bard

Terminated

Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation (MAGELLAN)

Paroxysmal Atrial Fibrillation

United States
C. R. Bard

Completed

Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. (EVEREST)

Pulmonary Embolism | Venous Thromboembolic Disease
Chugani, Diane C.

Completed

Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy

Autism

United States
C. R. Bard

Completed

Pivotal Study for the FLAIR Endovascular Stent Graft

Stenoses

United States
Dilla University

Not yet recruiting

Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial

Measles

Ethiopia
Dilla University

Completed

Pattern of Disease and Determinants of Clinical Outcomes Among ICU Patients (PDCO)

Clinical Outcomes

Ethiopia
Dilla University

Completed

Prophylactic Intrathecal Normal Saline for Prevention of Post Dural Puncture Headache in Women Undergoing Cesarean Section Under Spinal Anesthesia (PDPH)

PDPH

Ethiopia
C. R. Bard

Completed

Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon

Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Diseases

United States
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
C. R. Bard

Completed

Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

Incisional Hernia

United States
C. R. Bard

Terminated

SHERLOCK 3CG™ Diamond Tip Confirmation System (MODUS II)

Bundle-Branch Block | Tachycardia | Atrioventricular Block | Atrial Flutter | Premature Ventricular Contraction | Premature Atrial Contraction | Indication for Peripheral Intravenous Catheterization | Premature Junctional Contraction

United States, Australia
C. R. Bard

Completed

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Lung Cancer | Lung Tumor

United States
C. R. Bard

Completed

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)

Peripheral Vascular Disease | Venous Disease | May-Thurner Syndrome | Iliofemoral Occlusive Disease

United States, Australia, Germany, Ireland, Netherlands, Spain, United Kingdom
C. R. Bard

Completed

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease (BOLSTER)

Peripheral Vascular Disease | Peripheral Artery Disease | Arterial Occlusive Disease

United States, Germany, New Zealand
C. R. Bard

Completed

Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair

Hernia | Hernia, Abdominal | Hernia, Incisional

Belgium, Netherlands, Denmark, France, Italy, United Kingdom, Austria, Germany
C. R. Bard

Completed

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Peripheral Artery Disease

United States, Germany, Belgium, Austria, Switzerland
C. R. Bard

Terminated

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM") (CONTINUUM)

Superficial Femoral Artery Stenosis

United States
C. R. Bard

Completed

A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair

Ventral Hernia | Incisional Hernia

United States
C. R. Bard

Completed

Comparison of AccuCath IV Catheter and Conventional IV Catheter in Interventional Radiology

Vascular Access Complications

United States
C. R. Bard

Completed

Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department

Vascular Access Complication

United States
C. R. Bard

Completed

A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System (Luminexx)

Iliac Artery Occlusive Disease
C. R. Bard

Completed

FLAIR™ Delivery System Study (FLAIR DS)

Constriction, Pathologic

United States
C. R. Bard

Completed

PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis (PERVIDEO I)

In-Stent Restenosis

Netherlands, Belgium, Germany
C. R. Bard

Completed

A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repair Utilizing the AlloMax Surgical Graft (AlloMax)

Hernia

United States
C. R. Bard

Completed

Transoral Gastric Volume Reduction as an Intervention for Weight Management (TRIM)

Obesity

United States
C. R. Bard

Completed

A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System (REALITY2)

Peripheral Artery Disease

Germany
C. R. Bard

Terminated

Assessment of the Precision of the Sherlock 3CG Tip Positioning System (STAT-PICC)

No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement

United States
C. R. Bard

Terminated

Incisionless Treatment for Patients With Inadequate Weight Loss Following Roux-en-Y Gastric Bypass

Obesity

United States
C. R. Bard

Terminated

A Study of Complex Ventral Hernia Repair Utilizing the XenMatrix™ Surgical Graft With Component Separation (XenMatrix)

Hernia

United States
Dilşad Sindel

Completed

Investigation of the Effectiveness of Muscle Inhibition and Space Correction Techniques of Kinesiotaping Method in Female Patients With Myofascial Pain Syndrome Related to Upper Trapezius Active Trigger Points

Female Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP)
Ospedale C & G Mazzoni

Recruiting

Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure (AMY-CCM)

Heart Failure | Amyloidosis Cardiac

Italy
Bial - Portela C S.A.

Active, not recruiting

OpicApone Sleep dISorder (OASIS)

Parkinson Disease

Portugal
Bial - Portela C S.A.

Terminated

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

Pulmonary Arterial Hypertension
Bial - Portela C S.A.

Completed

Absorption, Distribution, Metabolism and Excretion of BIA 5-1058 (ADME)

Pulmonary Arterial Hypertension

Netherlands
Bial - Portela C S.A.

Completed

Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)

Parkinson Disease

United Kingdom
Nova Biomedical
C-TRIC

Completed

Study of the Analytical Performance of ALLEGRO™ Instrument

Diabetes

United Kingdom

3

Subscribe